OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $467,856 | +132.6% | 37,883 | +70.0% | 0.00% | – |
| Q2 2023 | $201,179 | +97.2% | 22,279 | -24.2% | 0.00% | – |
| Q1 2023 | $101,994 | +46.8% | 29,393 | +3.7% | 0.00% | – |
| Q4 2022 | $69,460 | +82.8% | 28,351 | +104.2% | 0.00% | – |
| Q3 2022 | $38,000 | -82.6% | 13,884 | -74.2% | 0.00% | – |
| Q2 2022 | $219,000 | -67.0% | 53,780 | -65.5% | 0.00% | – |
| Q1 2022 | $664,000 | -38.4% | 155,982 | +35.4% | 0.00% | – |
| Q4 2021 | $1,078,000 | +54.4% | 115,166 | +355.2% | 0.00% | – |
| Q3 2021 | $698,000 | +564.8% | 25,302 | +573.5% | 0.00% | – |
| Q2 2021 | $105,000 | -88.5% | 3,757 | -86.3% | 0.00% | – |
| Q1 2021 | $910,000 | +18100.0% | 27,416 | +28758.9% | 0.00% | – |
| Q4 2020 | $5,000 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $15,238,000 | 2.80% |
| Fairmount Funds Management LLC | 2,669,300 | $10,864,000 | 2.49% |
| BVF INC/IL | 7,611,503 | $30,979,000 | 1.50% |
| Vivo Capital, LLC | 1,689,515 | $6,876,000 | 0.69% |
| Cormorant Asset Management, LP | 2,082,000 | $8,474,000 | 0.64% |
| Newtyn Management, LLC | 500,000 | $2,035,000 | 0.39% |
| Kynam Capital Management, LP | 249,229 | $1,014,000 | 0.26% |
| Monaco Asset Management SAM | 130,000 | $529,000 | 0.23% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $1,298,000 | 0.20% |
| Artal Group S.A. | 260,500 | $1,060,000 | 0.06% |